Category: category-/Business & Industrial/Pharmaceuticals & Biotech

Insilico Medicine’s generative AI tool inClinico demonstrates high accuracy in predicting clinical trial outcomes

Insilico Medicine’s inClinico incorporates generative AI and years of multimodal data to forecast the outcomes of Phase II clinical trials.

Causaly raises $60M to fuel generative AI-powered drug discovery

Causality uses machine learning to automate the prior, heavily manual processes of biomedical research and drug discovery.